𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Screening for cognitive impairment in Parkinson’s disease – which marker relates to disease severity?

✍ Scribed by M. W. Riepe; J. Kassubek; F. Tracik; G. Ebersbach


Book ID
106206967
Publisher
Springer
Year
2006
Tongue
English
Weight
114 KB
Volume
113
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


The montreal cognitive assessment as a s
✍ David J. Gill; Arielle Freshman; Jennifer A. Blender; Bernard Ravina 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

## Abstract Cognitive impairment is common in Parkinson's disease (PD) and can occur early in the disease course. No effective screening test exists for detection of early or mild cognitive impairment in PD. We examined the Montreal Cognitive Assessment (MoCA) as a screening tool for cognitive dysf

Cognitive impairment in Parkinson's dise
✍ Jaime Kulisevsky; Javier Pagonabarraga 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

## Abstract Cognitive impairment (CI) and dementia are frequent and debilitating features associated with Parkinson's disease (PD). Formal neuropsychological examination is required to ascertain the degree and pattern of CI over the course of the disease. The use of different tools may explain hete

Subtypes of mild cognitive impairment in
✍ Carmen Cristea Janvin; Jan Petter Larsen; Dag Aarsland; Kenneth Hugdahl 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## Abstract The aim of this study was to establish the rate of progression from mild cognitive impairment (MCI) to dementia in patients with Parkinson's disease (PD). PD patients without dementia were recruited in 1997 from an ongoing prospective epidemiological study. The assessment included neuro

PDD-Short Screen: A brief cognitive test
✍ Javier Pagonabarraga; Jaime Kulisevsky; Gisela Llebaria; Carmen García-Sánchez; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

## Abstract The diagnosis of Parkinson's disease with dementia (PDD) is currently based on clinical criteria (DSM‐IV, MDS–Task Force). In daily practice and research studies, these criteria still depend on the subjective impression of the examiner. Brief screening tests (BST) are helpful in identif